Angioedema Treatment Market
According to Intent Market Research, the Angioedema Treatment Market is expected to grow from USD 4.8 billion in 2023 at a CAGR of 9.9% to touch USD 9.3 billion by 2030. The Angioedema Treatment Market is dominated by key players such as Shire Pharmaceutical, Sanofi S.A., CSL Behring, Ferring Pharmaceuticals, Pharming Group, Biocryst Pharmaceuticals, Roche Holding AG, AbbVie Inc., Grifols, Meda Pharmaceuticals (Mylan), Vertex Pharmaceuticals, Bayer AG, Teva Pharmaceuticals.